Sima P. Porten
University of California, San Francisco(US)UCSF Helen Diller Family Comprehensive Cancer Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Epigenetics and DNA Methylation, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis
Most-Cited Works
- → Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy(2014)1,717 cited
- → Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer(2020)723 cited
- → Epidemiology, Screening, and Prevention of Bladder Cancer(2022)308 cited
- → Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer(2010)282 cited
- → A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer(2015)275 cited
- → Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance(2011)198 cited